• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » GE plans ‘lab-in-a-box’ complex in Ireland

GE plans ‘lab-in-a-box’ complex in Ireland

September 20, 2016 By Sarah Faulkner

GE plans 'lab-in-a-box' complex in IrelandGE (NYSE:GE) reportedly plans to build 4 prefabricated drug factories in Cork, Ireland.

The U.S.-based company said yesterday that it plans to put $167 million (€150 million) into a biopharmaceutical campus in County Cork, with construction slated to begin next year, according to Reuters.

Both Pfizer (NYSE:PFE) and GE have prefab factories in China, designed to produce biosimilars – copies of pricey biotech drugs.

The GE BioPark in Cork is due have 500 jobs when it’s fully operational. Ireland sports a 12.5% corporate tax rate; 9 of the top 10 global drug companies have an international base in Ireland, the news service reported.

“Ireland is a real hub for biopharmaceuticals, so it’s logical to do it there,” Kieran Murphy, chief executive for life sciences at GE Healthcare, told the news service. “It’s one of the key places people are going in the world, along with Singapore, Korea and China.”

Although GE doesn’t have any buyers for the units in Cork yet, Murphy said, “I don’t think it will take us very long to snag the first customer.”

GE’s “lab-in-a-box” complex will be 25% to 50% cheaper than a traditional biopharmaceutical plant, it said. The modular factories can be constructed in just 18 months rather than the 3 years it takes to build a standard plant.

The announcement comes weeks after a dispute with an Irish labor union prompted GE Healthcare to withdraw job offers to prospective employees just a day before they were to start at a $44.7 million facility in East Cork, Ireland.

A dispute with the Services Industrial Professional & Technical Union over moving the plant from a 3-shift-a-day scheme to 4 shifts prompted GE to rescind offers from would-be employees, some of which had inked contracts with the imaging giant.

Filed Under: Biotech, Pharmaceutical, Wall Street Beat Tagged With: GE Healthcare

More recent news

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy